Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Cells|February 26, 2026
Beyond Ion Channels: Emerging Roles of FGF12 in Cellular Regulation and Cancer ProgressionZechao Huang, Xuesen DongCells|November 26, 2025
FGF12 Enhances Prostate Cancer Cell Survival via the YB1-lncRNA AxisZechao Huang, Sonia H Y Kung, Hans Adomat, et al.Plos One|November 1, 2014
Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cellsLiangliang Liu, Xuesen DongOncogene|December 11, 2019
Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapyXuesen Dong, Ruiqi ChenPharmaceuticals (Basel, Switzerland)|January 21, 2023
The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer TherapyVictor M Matias-Barrios, Xuesen DongFrontiers in Oncology|July 14, 2022
The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer ProgressionLin Gao, Bo Han, Xuesen DongThe Journal of Steroid Biochemistry and Molecular Biology|April 30, 2016
Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancerRuiQi Chen, Yue Yu, Xuesen DongBJU International|March 24, 2018
Molecular model for neuroendocrine prostate cancer progressionRuiqi Chen, Xuesen Dong, Martin GleaveJournal of Chemical Information and Modeling|July 21, 2020
The Use of Methods of Computer-Aided Drug Discovery in the Development of Topoisomerase II Inhibitors: Applications and Future DirectionsMariia Radaeva, Xuesen Dong, Artem CherkasovOncotarget|July 25, 2018
Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cellsRuiqi Chen, Yinan Li, Ralph Buttyan, et al.Pageof 9